Total value of top pharmaceutical venture financing deals 2014
This statistic displays the value of the top 10 venture financing deals worldwide within the pharmaceutical industry in 2014. In that year, Juno Therapeutics, a biotechnology company was given a venture capital deal valued at 134 million U.S. dollars. In the biotechnology industry, many corporate investors are funding innovation and research, however, high regulations on the market has lowered returns and made venture capital funds less prominent in recent years in this market.